Publicaciones (18) Publicaciones de GORKA IRIARTE SÁENZ DE OJER

2024

  1. The impact of prenatal mercury on neurobehavioral functioning longitudinally assessed from a young age to pre-adolescence in a Spanish birth cohort

    Environmental Research, Vol. 252

2023

  1. Exposure to mercury among Spanish adolescents: Eleven years of follow-up

    Environmental Research, Vol. 231

2022

  1. Pre and postnatal exposure to mercury and sexual development in 9-year-old children in Spain: The role of brain-derived neurotrophic factor

    Environmental Research, Vol. 213

2021

  1. Exposure to mercury among 9-year-old children and neurobehavioural function

    Environmental International, Vol. 146

  2. Pre and postnatal exposure to mercury and respiratory health in preschool children from the Spanish INMA Birth Cohort Study

    Science of the Total Environment, Vol. 782

2020

  1. Postnatal exposure to mercury and neuropsychological development among preschooler children

    European Journal of Epidemiology, Vol. 35, Núm. 3, pp. 259-271

2019

  1. Exposure to mercury among 9-year-old Spanish children: Associated factors and trend throughout childhood

    Environment International, Vol. 130

2014

  1. Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect

    Journal of Chromatography A, Vol. 1353, pp. 10-27

  2. Sindrome metabolikoa: XXI. mendearen madarikazioa

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 27, pp. 71-85

2010

  1. LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 878, Núm. 28, pp. 2685-2692

2009

  1. Optimization and validation of a SPE-HPLC-PDA-fluorescence method for the simultaneous determination of drugs used in combined cardiovascular therapy in human plasma

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 50, Núm. 4, pp. 630-639

  2. Validation of a fast liquid chromatography-UV method for the analysis of drugs used in combined cardiovascular therapy in human plasma

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 877, Núm. 27, pp. 3045-3053

2008

  1. Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method

    Journal of Separation Science, Vol. 31, Núm. 4, pp. 667-676

2007

  1. Biovalidation of an SPE-HPLC-UV-fluorescence method for the determination of Valsartan and its metabolite valeryl-4-hydroxy-valsartan in human plasma

    Journal of Separation Science, Vol. 30, Núm. 14, pp. 2231-2240

  2. Development of a solid phase extraction procedure for HPLC-DAD determination of several angiotensin II receptor antagonists in human urine using mixture design

    Talanta, Vol. 73, Núm. 4, pp. 748-756

2006

  1. MultiSimplex and experimental design as chemometric tools to optimize a SPE-HPLC-UV method for the determination of eprosartan in human plasma samples

    Talanta, Vol. 69, Núm. 3, pp. 747-756

  2. Optimization via experimental design of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite in human plasma samples

    Journal of Separation Science, Vol. 29, Núm. 15, pp. 2265-2283

  3. Validation of a solid phase extraction-high performance liquid chromatographic method for the determination of eprosartan in human plasma

    Journal of Chromatography A, Vol. 1119, Núm. 1-2, pp. 309-314